Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Antibodies targeting chemokine receptors CXCR4 and ACKR3.

Bobkov V, Arimont M, Zarca A, De Groof T, van der Woning B, de Haard H, Smit MJ.

Mol Pharmacol. 2019 Sep 3. pii: mol.119.116954. doi: 10.1124/mol.119.116954. [Epub ahead of print]

2.

CXCR4/ACKR3 phosphorylation and recruitment of interacting proteins: key mechanisms regulating their functional status.

Fumagalli A, Zarca A, Neves M, Caspar B, Hill SJ, Mayor F, Smit MJ, Marin P.

Mol Pharmacol. 2019 Mar 5. pii: mol.118.115360. doi: 10.1124/mol.118.115360. [Epub ahead of print]

3.

Enabling Virtual AAA Management in SDN-Based IoT Networks .

Zarca AM, Garcia-Carrillo D, Bernabe JB, Ortiz J, Marin-Perez R, Skarmeta A.

Sensors (Basel). 2019 Jan 12;19(2). pii: E295. doi: 10.3390/s19020295.

4.

Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonists.

Adlere I, Sun S, Zarca A, Roumen L, Gozelle M, Viciano CP, Caspar B, Arimont M, Bebelman JP, Briddon SJ, Hoffmann C, Hill SJ, Smit MJ, Vischer HF, Wijtmans M, de Graaf C, de Esch IJP, Leurs R.

Eur J Med Chem. 2019 Jan 15;162:631-649. doi: 10.1016/j.ejmech.2018.10.060. Epub 2018 Oct 30.

PMID:
30476826
5.

Nanobody-Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4-mediated HIV-entry and induce antibody effector functions.

Bobkov V, Zarca AM, Van Hout A, Arimont M, Doijen J, Bialkowska M, Toffoli E, Klarenbeek A, van der Woning B, van der Vliet HJ, Van Loy T, de Haard H, Schols D, Heukers R, Smit MJ.

Biochem Pharmacol. 2018 Dec;158:413-424. doi: 10.1016/j.bcp.2018.10.014. Epub 2018 Oct 17.

6.

Transport mechanism for calcium and phosphate in ram spermatozoa.

Zarca A, Rubinstein S, Breitbart H.

Biochim Biophys Acta. 1988 Oct 20;944(3):351-8.

PMID:
2460139

Supplemental Content

Support Center